Literature DB >> 16231908

Discovery of O-GlcNAc transferase inhibitors.

Benjamin J Gross1, Brian C Kraybill, Suzanne Walker.   

Abstract

O-GlcNAcylation of serine and threonine residues is a dynamic and essential post-translational modification involved in signaling pathways in eukaryotes. Studies of O-GlcNAcylation would be aided by small-molecule inhibitors of O-GlcNAc transferase (OGT), the sole enzyme know to mediate this modification, but discovery of such molecules has been hampered by poor expression of cloned OGT and lack of suitable high-throughput screens. This Communication describes the development an expression system to access large amounts of the catalytic domain of OGT and the implementation of a fluorescence-based substrate analogue displacement assay that has led to the discovery of a set of OGT inhibitors. This work lays the foundation for both structural and functional analysis of the catalytic domain of OGT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231908     DOI: 10.1021/ja0555217

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  103 in total

1.  Detection and analysis of proteins modified by O-linked N-acetylglucosamine.

Authors:  Natasha E Zachara; Keith Vosseller; Gerald W Hart
Journal:  Curr Protoc Protein Sci       Date:  2011-11

Review 2.  The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

Authors:  Natasha E Zachara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

3.  Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners.

Authors:  Seok-Ho Yu; Michael Boyce; Amberlyn M Wands; Michelle R Bond; Carolyn R Bertozzi; Jennifer J Kohler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

4.  Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.

Authors:  Christian Bindesbøll; Qiong Fan; Rikke C Nørgaard; Laura MacPherson; Hai-Bin Ruan; Jing Wu; Thomas Å Pedersen; Knut R Steffensen; Xiaoyong Yang; Jason Matthews; Susanne Mandrup; Hilde I Nebb; Line M Grønning-Wang
Journal:  J Lipid Res       Date:  2015-02-27       Impact factor: 5.922

5.  O-linked β-N-acetylglucosamine (O-GlcNAc) site thr-87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles.

Authors:  Yuliya Skorobogatko; Ashly Landicho; Robert J Chalkley; Andrew V Kossenkov; Gianluca Gallo; Keith Vosseller
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

Review 6.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

Review 7.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

Review 8.  The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.

Authors:  Richard D Semba; Hu Huang; Gerard A Lutty; Jennifer E Van Eyk; Gerald W Hart
Journal:  Proteomics Clin Appl       Date:  2014-02-19       Impact factor: 3.494

9.  Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes.

Authors:  Stephen A Whelan; Wagner B Dias; Lakshmanan Thiruneelakantapillai; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

10.  Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.

Authors:  Sara E S Martin; Zhi-Wei Tan; Harri M Itkonen; Damien Y Duveau; Joao A Paulo; John Janetzko; Paul L Boutz; Lisa Törk; Frederick A Moss; Craig J Thomas; Steven P Gygi; Michael B Lazarus; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2018-10-04       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.